© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Bladder Cancer
FDA Approves Avelumab as First-line Maintenance for Patients with Urothelial Carcinoma
July 01, 2020
The FDA approved avelumab for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma that has not progressed with first-line platinum-containing chemotherapy.
Phase III KEYNOTE-361 Trial Fails to Meet Primary End Points
June 10, 2020
The trial is evaluating pembrolizumab in combination with chemotherapy for the first-line treatment of patients with advanced or metastatic urothelial carcinoma.
Study Shows Promise for UGN-101 in Low-Grade Upper Tract Urothelial Cancer
May 10, 2020
The study, titled OLYMPUS, suggested that primary chemoablation of low-grade upper tract urothelial cancer with intracavitary UGN-101 resulted in clinically significant disease eradication.